Volume 21, Number 11—November 2015
Research
Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014
Table 1
Indicator |
Virus load
|
p value† | ||
---|---|---|---|---|
Low, Ct<26, no. (%) | Medium, Ct 27–33, no. (%) | High, Ct>34, no. (%) | ||
Vital status | ||||
Died, n = 41 | 8 (20) | 23 (56) | 10 (24) | 0.0044 |
Survived, n = 61 | 2 (3) | 32 (52) | 27 (44) | |
Composite severity status | ||||
Severe,‡ n = 48 | 8 (17) | 28 (58) | 12 (25) | 0.0060 |
Not severe, n = 54 | 2 (4) | 27 (50) | 25 (46) | |
Hospital location§ | ||||
ICU, n = 36 | 8 (22) | 21 (58) | 7 (19) | 0.018 |
General ward, n = 31 | 2 (6) | 16 (52) | 13 (42) | |
Symptom status¶ | ||||
Symptomatic, n = 30 | 2 (7) | 18 (60) | 10 (33) | 0.064 |
Asymptomatic, n = 30 | 0 | 14 (47) | 16 (53) |
*Ct, cycle threshold; ICU, intensive care unit; MERS-CoV, Middle East respiratory syndrome coronavirus.
†Ordinal χ2 test with 1 degree of freedom.
‡Severe is a composite of patients who died and patients who were admitted to the ICU.
§Among admitted patients.
¶Among surviving patients.
Page created: October 16, 2015
Page updated: October 16, 2015
Page reviewed: October 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.